Building the Future of
Israeli Biotech

About

Israel Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israeli-based biotech companies.

Based in Rehovot, Israel’s main Biotech hub, we invest exclusively in Biotech companies developing drugs. We don’t just invest in promising companies – we have the ability, experience and network required to identify the best opportunities and partner with our portfolio companies to help them go the distance. The biotechnology industry in Israel is growing with enormous potential and we are determined to realize its full potential and real value.

Strategy

“We invest in Israeli and Israeli related biotechnology and pharmaceutical companies with exceptional technologies or product opportunities based on strong scientific rationale and commercial potential.”

Our key asset is a unique team of nearly 30 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide our portfolio companies with hands-on guidance and support.

We provide our portfolio companies with the necessary resources for long-term sustainable growth. We provide them with access to network, executive talent, strategic, operational, and business development resources.

This approach enhances their value and the investor’s long-term capital appreciation, while strengthening Israel’s Biotech industry which increases investment opportunities.

Portfolio

Team

Venture Advisors

Partnerships

News

Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals

AL102 is a small molecule gamma secretase inhibitor with a differentiated clinical profile BOTHELL, Wash. and MONMOUTH JUNCTION, N.J., Feb. 06, 2024 (GLOBE NEWSWIRE) — Immunome, Inc. (Nasdaq: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today announced that it entered into a definitive asset purchase agreement with Ayala Pharmaceuticals, Inc. …

Contact

Israel Biotech Fund
HaOgen B, 4 Oppenheimer St., 
Rehovot 7670104, Israel

Parking (payable) available at the building.
972-72-2514-175

We would be happy to hear from you
and learn more about your company and
technology. Please feel free to contact us at: [email protected]